Should you acquire InfuSystems Holdings after the newest volatility gain?

It appears InfuSystems Holdings will continue to recover much faster as its share price surged up 0.84% today. The firm current daily volatility is 2.4 percent, with a beta of 0.91 and an alpha of 0.29 over Dow Jones Industrial. As many of us are excited about office supplies, it is fair to review InfuSystems Holdings. What exactly are InfuSystems Holdings shareholders getting in April?
Published over a year ago
View all stories for InfuSystems Holdings | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Rifka Kats

InfuSystems Holdings currently holds roughly 311 K in cash with 18.32 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
We provide advice to complement the regular expert consensus on InfuSystems Holdings. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.
Investing in InfuSystems Holdings, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding InfuSystems Holdings along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as InfuSystems Holdings. Your research has to be compared to or analyzed against InfuSystems Holdings' peers to derive any actionable benefits. When done correctly, InfuSystems Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in InfuSystems Holdings.

How important is InfuSystems Holdings's Liquidity

InfuSystems Holdings financial leverage refers to using borrowed capital as a funding source to finance InfuSystems Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. InfuSystems Holdings financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to InfuSystems Holdings' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of InfuSystems Holdings' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between InfuSystems Holdings's total debt and its cash.

InfuSystems Holdings Gross Profit

InfuSystems Holdings Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing InfuSystems Holdings previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show InfuSystems Holdings Gross Profit growth over the last 10 years. Please check InfuSystems Holdings' gross profit and other fundamental indicators for more details.

InfuSystems Holdings Correlation with Peers

Investors in InfuSystems can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in InfuSystems Holdings. Diversification will allow for the same portfolio return with reduced risk. The correlation table of InfuSystems Holdings and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities InfuSystems is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of InfuSystems for more details

What is driving InfuSystems Holdings Investor Appetite?

InfuSystems Holdings appears to be somewhat reliable, given 3 months investment horizon. InfuSystems Holdings holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had 0.12% of return per unit of risk over the last 3 months. Our standpoint towards determining the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for InfuSystems Holdings, which you can use to evaluate the future volatility of the firm. Please utilize InfuSystems Holdings' Downside Deviation of 2.61, risk adjusted performance of 0.1045, and Market Risk Adjusted Performance of 0.2985 to validate if our risk estimates are consistent with your expectations.
FEMY
GCTK
MSFT
XOM
CVX
FEMY
-0.40.420.5-0.08
FEMY
GCTK
-0.4-0.31-0.740.32
GCTK
MSFT
0.42-0.310.44-0.39
MSFT
XOM
0.5-0.740.440.07
XOM
CVX
-0.080.32-0.390.07
CVX
FEMY
GCTK
MSFT
XOM
CVX
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

InfuSystems is expecting lower volatility in April

Newest skewness indicator falls down to -0.34. Possible price appreciation? InfuSystems Holdings currently demonstrates below-average downside deviation. It has Information Ratio of 0.11 and Jensen Alpha of 0.29. However, we advise investors to further question InfuSystems Holdings expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure InfuSystems Holdings' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact InfuSystems Holdings' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Final Perspective on InfuSystems Holdings

Whereas many other companies under the medical instruments & supplies industry are still a bit expensive, InfuSystems Holdings may offer a potential longer-term growth to private investors. With a less-than optimistic outlook for your 90 days horizon, it may be a good time to drop some or all of your InfuSystems Holdings holdings as it seems the potential growth was already fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to InfuSystems Holdings.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of InfuSystems Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to [email protected]